1Child III CG,Turcotte JG.Surgery and Portal Hypertension[M].In:Child III CG,ed.The liver and Portal hypertension.Philadelphia:Saunders,1964:50.
2Gallegos-Orozco JF,Vargas HE.Liver transplantation:from Child to MELD.[J].Med Clin North Am,2009,93(4):931-950.
3Pugh RN,Murray-Lyon IM,Dawson JL,et al.Transection of the oesophagus for bleeding oesophageal variees[J].Br J Surg,1973,60(8):646-649.
4Raszeja-Wyszomirska J,Wasilewicz MP,Wunsch E,et al.Assessment of a modified Child-Pugh-Turcotte score to predict early mortality after liver transplantation[J].Transplantation Proceedings,2009,41(8):3114-3116.
5Gitto S,Biselli M,Gramenzi A,et al.A modified Child-Turcotte-Pugh(CTP)for selection of patients affected by cirrhosis candidates to liver transplantation(LT)with low model for end-stage liver disease score(MELD)[J].J Hepatol,2010,52(Suppl 1):S135.
6Triantos C,Zisimopoulos K,Tsochatzis E,et al.Meld vs cps for prognosis in cirrhosis.Results from a multicentre study[J].J Hepatol,2010,52(Suppl 1):S89.
8Malinchoc M,Kamath PS,Gordon FD,et al.A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts[J].Hepatology,2000,31(4):864-871.
9Kamath PS,Wiesner RH,Malinchoc M,et al.A model to predict survival in patients with end-stage liver disease[J].Hepatology,2001,33(2):464-470.
10Kim JD,Choi JY,Kwon JH,et al.Performance of posttransplant Model for End-Stage Liver Disease(MELD)and delta-MELD scores on short-term outcome after living donor liver transplantation[J].Transplant Proc,2009,41(9):3766-3768.
10Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646. 被引量：829
